One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America

Journal Title: Jornal de Pediatria - Year 2017, Vol 93, Issue 5

Abstract

Objective This study aims to describe real world palivizumab use and effectiveness in high-risk Latin American infants and young children. Method Prospective, multicenter observational study with infants at risk for severe RSV infection who received palivizumab according to routine clinical practice. Subjects were followed for one year with monthly visits after the first dose of palivizumab. An infant was considered adherent if receiving all the expected injections or five or fewer injections within appropriate inter-dose intervals. Annual incidence rates and risk factors of lower respiratory tract infection (LRTI) hospitalization were determined through Poisson regression models (α=0.05). Results The study enrolled 458 children from seven countries in Latin America, from February 2011 to September 2012. The majority (98%) were born <36 weeks gestation. Overall, patients received 83.7% of their expected injections and 86.7% completed one year of follow-up. Of the 61 LRTI hospitalizations, 12 episodes were due to RSV infection. The RSV-associated hospitalization rate was 2.9 per 100 patient-years. Bronchopulmonary dysplasia was identified as an independent risk factor for LRTI hospitalization. A total of 1165 adverse events were recorded during one year of follow-up. One hundred and two patients (22.3%) had a total of 135 serious adverse events, but no events were considered to be related to palivizumab. Conclusions The rate of RSV hospitalization in high-risk infants in Latin America was low and aligned with those observed in randomized control trials and observational studies. Palivizumab prophylaxis appeared effective and had a good safety profile in this population.

Authors and Affiliations

Gabriela Bugarin

Keywords

Related Articles

Translation and validation of the Transition Readiness Assessment Questionnaire (TRAQ)

Objective To translate and validate the Brazilian Portuguese version of the Transition Readiness Assessment Questionnaire in a population of adolescents and young adults with chronic rheumatologic disorders. This questio...

Child development in primary care: a surveillance proposal

Objective To evaluate a child development surveillance tool proposal to be used in primary care, with simultaneous use of the Denver II scale. Methods This was a cross-sectional study of 282 infants aged up to 36 months...

Duodenal pathologies in children: a single-center experience

Objective Several studies have been performed concerning pathologies of the stomach and esophagus in the pediatric age group. However, there have been very few studies of duodenal pathologies in children. The authors aim...

Hyperuricemia is associated with low cardiorespiratory fitness levels and excess weight in schoolchildren

Objective To evaluate the possible association between hyperuricemia and cardiorespiratory fitness levels/nutritional profile, grouped into a single variable, in schoolchildren. Method Cross-sectional study of 2335 stud...

Sepsis-associated acute kidney injury – is it possible to move the needle against this syndrome?

On the one hand, sepsis is the leading cause of non-trauma related death in pediatric patients across the world, in both developed and developing nations.1 On the other hand, epidemiologic data demonstrate the independen...

Download PDF file
  • EP ID EP503536
  • DOI 10.1016/j.jped.2016.11.006
  • Views 60
  • Downloads 0

How To Cite

Gabriela Bugarin (2017). One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America. Jornal de Pediatria, 93(5), 467-474. https://europub.co.uk/articles/-A-503536